| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | President and CEO, Director | $1.08M | +$14.7K | +1.38% | Nov 10, 2025 |
| BPMC | Blueprint Medicines Corp | Director | $0 | Jul 17, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|